Companies Investors People

Loading

aVenture is in Alpha: during this preview period, research data is limited and may not yet meet our exacting standards. We've chosen to provide early access to showcase the product as we build, so you should not rely on it alone for your investment decisions.

aVenture is in Alpha: during this preview period, research data is limited and may not yet meet our exacting standards. We've chosen to provide early access to showcase the product as we build, so you should not rely on it alone for your investment decisions.

Get in touch

Contact
Request a demo
Request data updates
Add a company

Research

Companies
Investors
People

aVenture

Sitemap
Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Bios Health - aVenture Company Research

Bios Health

AddedMar 21, 2024

UpdatedJun 30, 2026

Bios Health

BIOS Health: Pioneering neural interfaces for medical advancements in the UK.

HQ

Cambridge, Cambridgeshire, GB

Founded

Accelerator

Y Combinator W17

Bios Health, originally known as Cambridge Bio-Augmentation Systems (CBAS), was founded with the mission to revolutionize medical treatments through advanced neural interfaces. The company focuses on decoding nerve data to develop precision medicine solutions. Their core products and services include AI-driven neural interfaces designed to understand and manipulate nerve signals for various medical applications. Bios Health aims to lead the market in neural treatments, leveraging cutting-edge technology to address complex neurological disorders.

Notable figures affiliated with Bios Health include experts in neuroscience, AI, and medical technology, although specific names are not provided. The company has attracted significant attention and investment from leading venture capital firms interested in healthcare innovation. Key achievements include pioneering advancements in neural interface technology and contributing to the emerging field of precision medicine. Bios Health's impact is profound, as it opens new possibilities for treating neurological conditions and enhancing the quality of life for patients worldwide.

Bios Health - Similar Companies

DocSpera

docspera.com

PatientIQ

patientiq.io

Bios Health - Quick Facts

Who are Bios Health's competitors?

Companies similar to Bios Health include DocSpera, PatientIQ, CipherHealth and Clario.

When was Bios Health founded?

Bios Health was founded in 2015.

Where is Bios Health's headquarters located?

Bios Health's headquarters is located in Cambridge, Cambridgeshire, GB.

When was Bios Health's last funding round?

Bios Health's most recent funding round was for $20M (USD) in June 2023.

How much has Bios Health raised to-date?

As of Jun 22, 2023, Bios Health has raised a total of 46.6M.

How many employees does Bios Health have?

Bios Health has 40 employees as of Feb 24, 2024.

Bios Health - Classification

Ownership: Private Equity
Venture Capital
Technology: AI
Machine Learning
Geographic Exposure: Europe

Model

Platform

Revenue

Recurring
Software

Customer

Enterprise

Tags: Biotech
Healthtech

NAICS: 513200Software Publishers
510000Information
513000Publishing Industries
513210Software Publishers
SIC: 7300Business Services
7370Computer Programming, Data Processing, And Other Computer Related
7372Prepackaged Software

Show 6 more industry codes

NAICS: 540000Professional, Scientific, and Technical Services
541500Computer Systems Design and Related Services
541000Professional, Scientific, and Technical Services
541510Computer Systems Design and Related Services
541511Custom Computer Programming Services
SIC: 7371Computer Programming Services

CipherHealth

cipherhealth.com

Clario

clario.com

Vivalink

vivalink.com

Koneksa Health

koneksahealth.com

OpenClinica

openclinica.com

Huma

huma.com

Empatica

empatica.com

Boston Scientific

Medtronic

medtronic.com

Saluda Medical

saludamedical.com

Precision Neuroscience

precisionneuro.io

Paradromics

paradromics.com

Blackrock Neurotech

Bios Health - Products & Services

BIOS Health: Reports
BIOS Health: Reports is a web portal where clinicians and researchers view and export study data.
Competing Products
BIOS Health: Tracker
BIOS Health: Tracker is an Apple Watch app computing health metrics and six-minute walk tests for clinical studies.
Competing Products
BIOS Health: Clinical Studies
BIOS Health: Clinical Studies is an Android and iOS app for study enrolment and symptom and quality-of-life surveys.
Competing Products
BIOS Remote Health Platform
The BIOS Remote Health platform collects wearable patient data and turns it into outcome measures for researchers and clinicians.
Competing Products
BIOS NeuroTune
BIOS NeuroTune is a dosing AI co-pilot that personalises neuromodulation device settings in under ten minutes.
Competing Products
Neural Interface and AI Platform
BIOS Health's neural interface and AI platform reads and writes neural data to discover neural biomarkers for precision medicine.
Competing Products